JB Chemicals & Pharmaceuticals Limited has informed the Exchange about proceedings of the NCLT convened meeting
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JB Chemicals & Pharmaceuticals Limited held an NCLT-convened equity shareholders meeting on April 28, 2026 via video conferencing. The meeting was convened to seek shareholder approval for a Scheme of Amalgamation whereby JB Chemicals will merge into Torrent Pharmaceuticals Limited. The scheme received approval from shareholders with the requisite majority under Section 230(6) of the Companies Act, 2013 — requiring both a simple majority of shareholders and a 3/4th majority in value. Voting was conducted through remote e-voting and e-voting at the meeting. The results and scrutinizer's report will be disclosed separately. The meeting concluded within 33 minutes with proper quorum present.
Shareholder approval marks a significant milestone in the merger process. JB Chemicals shareholders will receive Torrent Pharmaceuticals shares upon scheme completion. This amalgamation could create synergies and is typically positive for both companies' valuations. The stock may see increased volatility as the market reacts to this consolidation news.